Institutional investors hold a majority ownership of BMY through the 71.68% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Major industry. Last, during the quarter ended September 2016, these large investors purchased a net $50.3 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
DAVENPORT & CO. LLC Bought 1.0 Million shares of Bristol-Myers Squibb